DR. JAMES BRIAN MACDOUGALL, MD

Plain English
This study looked at the safety and effectiveness of a medication called NG101 for treating gastroparesis, a condition that causes nausea and stomach discomfort. It involved 161 participants over 12 weeks, and while NG101 did not significantly reduce nausea severity compared to a placebo, patients reported feeling better about their nausea overall during the treatment period. This research is important as it shows NG101 may be a safe option with some positive outcomes, especially for patients with idiopathic gastroparesis. Who this helps: This helps patients suffering from gastroparesis, particularly those with idiopathic gastroparesis.

Plain English
This study focused on children with permanent hearing loss (PHL) and how often they use healthcare services compared to other children. Researchers found that 39.9% of children with PHL had chronic complex conditions, compared to just 8.1% of their matched peers. Additionally, these children made 25% more emergency visits, 44% more outpatient visits, and stayed in the hospital for 62% longer than the control group in their first two years of life. Understanding these patterns helps improve healthcare planning and support for affected children. Who this helps: This helps healthcare providers and families of children with hearing loss.

Plain English
This study focused on a 16-year-old girl with complete androgen insensitivity syndrome (CAIS), a condition where individuals have female characteristics despite having male genetic markers. After removing her testes due to cancer risk, doctors preserved part of the tissue to explore possible fertility options. The finding that there were no definite germ cells in her tissue is important because it informs future decisions about fertility preservation for patients with CAIS. Who this helps: This benefits young women with CAIS and their families, as well as healthcare providers navigating treatment options.

Plain English
This study looked at how to better involve parents in caring for their babies' pain during medical procedures in rural areas. Researchers interviewed 24 people, including healthcare providers and parents, and found 32 key issues affecting this involvement, such as access to resources and social support. Addressing these issues is important to improve pain management practices for infants, leading to better care and outcomes in rural settings. Who this helps: This benefits parents and healthcare providers in rural communities.

Plain English
This study looked at whether using two medications that block a molecule linked to migraines—one given by injection and one taken orally—can help people with chronic migraines. Among 37 patients, those who used both medications reported an average decrease of headache days, with almost a quarter seeing their headaches cut by more than half. This matters because it shows that combining these treatments can provide relief for patients who haven't had success with other options. Who this helps: This helps patients suffering from chronic migraines who need more effective treatment solutions.

Plain English
This study looked at how Epidiolex, a medication made from cannabidiol (CBD), affects seizure frequency and anxiety in children with hard-to-treat epilepsy. Out of 12 children, 73% showed improvements in both anxiety and seizure rates after taking Epidiolex for 4 to 6 weeks, with minimal side effects. These findings are significant because they suggest that Epidiolex not only helps control seizures but may also reduce anxiety in kids who struggle with both issues. Who this helps: This helps children with epilepsy and their families, as well as the doctors treating them.

Plain English
The study compared a new treatment called I-apamistamab to standard care for older patients with difficult-to-treat acute myeloid leukemia (AML) who needed a stem cell transplant. Researchers found that 17.1% of patients receiving I-apamistamab achieved a lasting complete remission, while none in the standard care group did. This treatment is significant because it offers hope for improving outcomes in a patient group that currently has very few effective options. Who this helps: Older patients with relapsed or refractory AML.

Plain English
This study looked at the effects of switching patients with rheumatologic diseases from the original infliximab medication to cheaper biosimilars. Out of 48 patients who switched, 8 (about 42%) experienced a flare-up of their condition after the change, and a quarter of those had delays in receiving treatment due to insurance issues. This is significant because it highlights that many patients may lose control of their disease after switching, suggesting that careful monitoring is crucial during the transition. Who this helps: This helps patients with rheumatologic diseases and their doctors by emphasizing the need for close follow-up after switching medications.

Plain English
This study tested a new drug called Sevasemten in healthy adults and those with Becker muscular dystrophy (BMD). Researchers found that, after treatment, people with BMD experienced significant decreases in muscle injury markers: creatine kinase levels dropped by 70%, fast skeletal muscle troponin I by 98%, and myoglobin by 45%. These findings show that Sevasemten might help reduce muscle damage, which is important for improving the lives of people with BMD. Who this helps: This benefits patients with Becker muscular dystrophy.

Plain English
This study looked at oral food challenges, which are tests used to diagnose food allergies. The researchers found that while these tests are expensive and risky, they are still the best way to determine whether someone can safely eat a potentially harmful food. Proper training and standardized procedures for these tests are crucial to keep patients safe during the process. Who this helps: Patients with food allergies and their healthcare providers.

Plain English
This study looked at how to effectively include pharmacy students in hospital clinical services during their training. It involved 71 students and 166 supervisors, with interviews showing that both groups found the students' involvement beneficial for learning and patient care. The research identified six key areas that helped students learn and contribute meaningfully to the pharmacy team, which is important for improving training programs. Who this helps: This benefits pharmacy students and their supervisors in hospitals.

Plain English
This study looked at how a mentorship program helps newly graduated nurse practitioners (NPs) in Nova Scotia adjust to their new roles. It found that the first six months are crucial for NPs as they start to define their professional identity, but many still face challenges with their work and support after a year. The research highlights the need for flexible mentorship that adapts to the changing needs of NPs. Who this helps: This benefits new nurse practitioners as they transition into their careers.

Plain English
This study looked at how well miltefosine, a drug used to treat visceral leishmaniasis (a serious disease caused by parasites), works in monkeys infected with the disease. The researchers found that even after treatment, the parasites were still present in various tissues, such as the spleen and bone marrow, three months later. The study shows that miltefosine doesn’t completely clear the infection and leads to significant changes in immune cells that could keep the infection going, which is crucial for understanding how to better treat this disease. Who this helps: This information benefits doctors and researchers working on treatments for visceral leishmaniasis.

Plain English
Researchers studied the ability of small zirconia nanoparticles to absorb terahertz (THz) and sub-terahertz waves, which are important for technologies like 5G communication. They found that the smallest nanoparticles (around 2.6 nm) had the highest absorption value of 1.11 mm, compared to larger particles that absorbed much less (0.04 and 0.18 mm). This is important because better absorption materials can help reduce noise in THz technologies, improving their performance. Who this helps: This helps engineers and developers of wireless technologies.

Plain English
The study explored bacteria found in freshwater ponds near monuments in Washington, DC, by analyzing their genetic material. Researchers identified three types of bacteria, two of which might be new species, but these could not be revived for further study. This research is important for understanding the diversity of bacteria in our environment and their potential roles. Who this helps: This helps scientists and environmental researchers studying aquatic ecosystems.

Plain English
This research focused on a new type of heat-storage material made from lambda-trititanium-pentoxide, which can hold onto heat for longer periods than traditional materials. The study found that this ceramic can store thermal energy efficiently and release it when needed, significantly broadening its potential uses. This discovery is important because it could lead to better ways to use waste heat energy, helping reduce energy consumption in various industries. Who this helps: This benefits industries looking for more efficient energy solutions.

Plain English
This study looked at a woman with a specific type of Turner syndrome and polycystic ovary syndrome (PCOS) who successfully had her eggs retrieved and frozen. After going through two rounds of treatment, she ended up with 19 frozen eggs. This is important because it shows that women with Turner syndrome mosaicism can have options for preserving their fertility, even if they also have PCOS. Who this helps: Patients with Turner syndrome and their healthcare providers.

Plain English
This study looked at how COVID-19 changed the way dermatologists in cities provided care for their patients. Researchers found that during the height of the pandemic, patient visits dropped by over 65%, but by July 2020, this decline improved to about 15%. Even with fewer patients, there were more urgent skin issues and cancer concerns, highlighting the need for dermatologists to adapt their practices, such as using telehealth and adjusting operations to keep both staff and patients safe. Who this helps: This benefits both patients and dermatologists by ensuring timely care while maintaining safety during the pandemic.

Plain English
This study looked at how Nova Scotia Health organized its workforce to address challenges during the COVID-19 pandemic. They found that there were significant shortages of staff in various healthcare roles, which would impact patient care. By taking action to increase the number of qualified workers, they were able to ensure that enough personnel were available to care for COVID-19 patients during the third wave of the pandemic, which is important for managing healthcare effectively moving forward. Who this helps: This helps patients and healthcare providers by ensuring that there are enough staff to care for those affected by COVID-19.

Plain English
This study looked at how to improve the use of simple, effective methods for easing pain in infants, like breastfeeding and skin-to-skin contact, which are often overlooked in hospitals. Researchers explored the challenges and support needed for parents to use these pain relief techniques during medical procedures and worked on designing practical solutions. Ultimately, their findings aim to enhance pain care for infants, which is crucial for improving their health and safety. Who this helps: This helps infants and their families receive better pain management during medical care.

Plain English
This study looked at a new type of laser that can send data very quickly over fiber optic cables. The researchers found that this laser can successfully transmit data at 30 gigabits per second over distances of up to 75 kilometers without needing extra amplifiers. This is important because it could improve internet speeds and connect more people, particularly in areas where upgrading existing infrastructure is challenging. Who this helps: This benefits internet service providers and their customers.

Plain English
This study looked at a new treatment called ENT-01 to help relieve constipation in people with Parkinson's disease (PD). Over 25 days, patients taking ENT-01 had an increase in their weekly complete bowel movements from 0.7 to 3.2, while those on a placebo only increased from 0.7 to 1.2. This is important because constipation can significantly impact the quality of life for people with PD, and ENT-01 not only improved bowel movements but also showed signs of helping with related symptoms like dementia and psychosis. Who this helps: This helps patients with Parkinson's disease who suffer from constipation and related gastrointestinal issues.

Plain English
This study focused on how to better determine the right dose of vancomycin, an antibiotic, for patients with severe obesity. Researchers found that using a method focused on achieving a specific concentration over time (target AUC) required less medication—about 2,783 mg compared to 3,995 mg with the traditional method of monitoring trough levels—making it a more effective option. This matters because it could lower the chances of kidney damage from too high a dose of the drug in these patients. Who this helps: This helps patients with class III obesity who need vancomycin treatment.

Plain English
This study tested a new drug called edasalonexent in young boys with Duchenne muscular dystrophy, a condition that weakens muscles over time. The research found that when the boys took 100 mg/kg of edasalonexent daily, their disease progression slowed, and their muscle health improved, with fewer signs of inflammation. These findings are important because they suggest that edasalonexent could help preserve muscle function in boys with this condition and guide future research. Who this helps: This helps boys with Duchenne muscular dystrophy.

Plain English
This study focused on a specific enzyme called ribose 5-phosphate isomerase B (RpiB) in the parasite Leishmania infantum, which causes serious tropical diseases. Researchers tested many small chemical pieces (fragments) to see if they could effectively block this enzyme and found that some of these fragments could successfully stop the growth of the parasite. These findings are important because they identify RpiB as a potential target for new drug development, which is crucial for treating infections caused by this parasite. Who this helps: This helps patients suffering from leishmaniasis and other infections caused by related parasites.

Plain English
This study tested a new drug called edasalonexent in children aged 4 to under 8 years who have Duchenne muscular dystrophy, a condition that weakens muscles. Over a year, 131 kids took either edasalonexent or a placebo, and while the overall results didn’t show a clear improvement in muscle function measures, younger children (under 6 years old) did show some positive effects. This matters because starting treatment early may help slow down muscle decline in these young patients. Who this helps: Younger patients with Duchenne muscular dystrophy.

Plain English
This study looked at a new treatment method for pancreatic cancer, specifically how a drug called BXCL701 can improve the effectiveness of another cancer treatment known as anti-PD1 therapy. The researchers found that using BXCL701 with anti-PD1 resulted in increased immune cells, like natural killer (NK) cells and CD8+ T cells, in tumors and reduced tumor growth—up to 50% smaller tumors in mice. Importantly, this combination treatment led to lasting immune responses that even cleared some tumors after further exposure, highlighting the potential for better outcomes in patients. Who this helps: This benefits patients with pancreatic cancer by offering a potential new treatment option.

Plain English
This study looked at a new treatment called zilucoplan for patients with moderate to severe generalized myasthenia gravis (gMG), a condition that causes muscle weakness. Among 44 patients, those who received the higher 0.3 mg/kg dose of zilucoplan saw their muscle weakness scores improve by an average of 6 points over 12 weeks compared to those on a placebo, which suggests the treatment is effective. This improvement matters because it shows that zilucoplan can help patients feel better and perform daily activities more easily without the commonly experienced side effects from traditional treatments. Who this helps: Patients with moderate to severe generalized myasthenia gravis.

Plain English
This study looked at how three antileishmanial drugs—amphotericin B (AmB), miltefosine, and pentamidine—affect human immune cells. The researchers found that all three drugs slowed down the growth of certain immune cells, but AmB also triggered the release of specific inflammatory signals that could affect immune responses. Importantly, they discovered that manipulating those signals could potentially restore the immune cell growth inhibited by AmB. Who this helps: This research benefits patients being treated for leishmaniasis, as it provides insights into how treatments can affect their immune systems.

Plain English
This study looked at two siblings who both had a rare genetic condition called normosmic idiopathic hypogonadotropic hypogonadism (IHH), which causes delayed puberty and fertility issues. They found that both siblings had a new genetic variant affecting a hormone crucial for puberty, with the boy showing symptoms by age 17 and the girl by age 16. This research is important because early diagnosis and treatment can help affected individuals develop normally and avoid long-term health and psychological problems. Who this helps: Patients with hypogonadotropic hypogonadism and their families.

Plain English
This study looked at a kidney transplant patient who developed unexpected milk production and high levels of prolactin while taking a medication called omeprazole to treat stomach issues. The researchers found that the omeprazole might not be properly removed from her body due to her kidney condition, leading to harmful effects on her kidneys and the unusual symptom of galactorrhea. This is important because it highlights the need for careful evaluation of common medications in patients with kidney problems to prevent serious side effects. Who this helps: Patients with kidney transplants and their doctors.

Plain English
This study looked at how well a blood test can predict cytomegalovirus (CMV) infections in kidney transplant patients. Researchers tested 583 patients and found that those who had a positive test result had a much lower risk of CMV infection (3.0%) compared to those with a negative result (19.5%). This is important because being able to accurately predict CMV infections can help doctors protect patients after transplant. Who this helps: This benefits kidney transplant patients and their doctors.

Plain English
This study looked at a new treatment called Nexvax2 for people with celiac disease, aiming to help them tolerate gluten. Researchers compared how well the treatment worked when given as an injection under the skin (subcutaneous) versus just below the skin (intradermal). They found that both methods provided similar levels of the treatment in the body, and the subcutaneous method helped reduce negative immune reactions to gluten, with mild side effects reported. Who this helps: This benefits patients with celiac disease looking for better ways to manage their gluten intolerance.

Plain English
Researchers studied how gluten affects people with coeliac disease by giving them a small amount of gluten and measuring their symptoms and a protein called interleukin-2 in their blood. They found that 92% of coeliac patients showed elevated interleukin-2 levels four hours after eating gluten, which matched the worsening of symptoms like nausea and vomiting. This research highlights that tracking interleukin-2 levels can help doctors diagnose coeliac disease in patients who already follow a gluten-free diet. Who this helps: This helps patients with coeliac disease and their doctors.

Plain English
This study examined how to tell apart two conditions that cause high fat levels in the blood: familial chylomicronemia syndrome (FCS) and multifactorial severe hypertriglyceridemia (sHTG). Researchers looked at data from 154 patients and found that they could correctly diagnose 45 out of 49 patients with FCS and 99 out of 105 patients with sHTG, achieving an impressive accuracy of 93.5%. This is important because correctly diagnosing these conditions can improve patient care and treatment options. Who this helps: Patients with these metabolic disorders and their healthcare providers.

Plain English
This study looked at the side effects experienced by 393 adults with Gaucher disease type 1 who took eliglustat, an oral medication. Out of these patients, 334 reported having one or more side effects, but 92% continued with the treatment, and only 3% stopped because of a side effect. Most of the side effects were mild or moderate, with none being serious enough to require stopping the drug, which is important for ensuring that patients can maintain their treatment. Who this helps: This benefits patients with Gaucher disease type 1 and their doctors by providing clarity on the safety and tolerability of eliglustat.

Plain English
Researchers studied a protein from the parasite that causes Chagas disease to see if they could develop new drugs to treat the illness. They found that a compound called BNIP Spermidine (BNIPSpd) was the most effective at inhibiting the protein and showed potential similar to an existing drug, but it didn't work in a mouse model for the disease. This is important because Chagas disease is a major health issue in Latin America, and finding new treatments could greatly help patients. Who this helps: Patients with Chagas disease.

Plain English
Researchers developed a new technique to study liquids under high pressure using soft x-rays. They found that a specialized thin membrane could contain liquids under pressures greater than 60 bars while allowing x-rays to pass through. This advancement is important because it enables detailed analysis of liquid properties at high pressure, which can improve our understanding of various materials and chemical processes. Who this helps: This benefits scientists and researchers studying advanced materials and chemical reactions under high-pressure conditions.

Plain English
This study looked at how the T-SPOT.TB test, used to detect tuberculosis (TB) infections, can more accurately identify cases that fall near the test's cut-off point by including a "borderline" category. Researchers analyzed nearly 646,000 tests and found that 1.8% were borderline. Among these borderline results, 59.2% turned out to be negative, while 20% turned positive upon retesting, indicating that the borderline category can help better determine a person's TB status and prevent misclassifications. Who this helps: This benefits patients and doctors by providing clearer test results, especially for those at risk for TB.

Plain English
This study examined the structure of a protein called LiSir2rp1 from the Leishmania infantum parasite, which causes the disease leishmaniasis. Researchers found that this protein has a distinct shape that is similar to proteins from yeast and humans, revealing important details about how it interacts with other molecules. Understanding this protein's structure is important because it could lead to new drugs targeting it, which is crucial for the survival of the parasite and could help treat infections in patients. Who this helps: This helps patients suffering from leishmaniasis.

Plain English
This study focused on developing a standardized method for collecting and analyzing biological samples to find potential new markers for chronic low back pain (CLBP). Researchers tested their procedure across five different centers and confirmed it was effective, ensuring that the samples collected were consistent and reliable. This is important because it lays the groundwork for future research aimed at creating personalized treatments for CLBP, a condition that affects millions of people. Who this helps: Patients suffering from chronic low back pain.

Plain English
This paper discusses how the European Commission can improve funding for developing new drugs for neglected tropical diseases (NTDs). The authors recommend that the EC focus on supporting the entire process of turning promising compounds into drugs ready for clinical trials. Making these changes could lead to more effective treatments for diseases that currently lack sufficient attention and funding. Who this helps: Patients suffering from neglected tropical diseases.

Plain English
This study examined the use of kidneys from deceased donors who died due to ethylene glycol (EG) poisoning to find out if they can still be safely transplanted. The researchers discussed the challenges and potential processes for using these kidneys, emphasizing that every possible organ should be considered to address the shortage of transplantable organs. This is important because there's a rising number of patients on waiting lists who could benefit from these organs, potentially saving lives as we improve the use of all available kidneys. Who this helps: This helps patients in need of kidney transplants.

Plain English
This study is examining the biological markers related to chronic low back pain (CLBP) to better understand its causes and improve treatment. Researchers will collect data from 12,000 people, including 4,000 with CLBP and 8,000 without, focusing on genetics and other biological factors. The goal is to identify specific genetic traits and other biomarkers that could help personalize and enhance treatment for those suffering from this condition. Who this helps: Patients with chronic low back pain.